User profiles for Catherine Z. Chen

Catherine Z Chen

National Center for Advancing Translational Sciences
Verified email at mail.nih.gov
Cited by 3857

[PDF][PDF] Human pluripotent stem cell-derived neural cells and brain organoids reveal SARS-CoV-2 neurotropism predominates in choroid plexus epithelium

…, SZH Wong, H Zhou, B Cubitt, W Fan, CZ Chen… - Cell stem cell, 2020 - cell.com
Neurological complications are common in patients with COVID-19. Although severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), the causal pathogen of COVID-19, has …

Identification of SARS-CoV-2 3CL protease inhibitors by a quantitative high-throughput screening

W Zhu, M Xu, CZ Chen, H Guo, M Shen… - ACS pharmacology & …, 2020 - ACS Publications
The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has emphasized the urgency to develop effective …

Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs

…, G Tawa, P Shinn, CZ Chen… - Emerging microbes & …, 2014 - Taylor & Francis
In light of the current outbreak of Ebola virus disease, there is an urgent need to develop
effective therapeutics to treat Ebola infection, and drug repurposing screening is a potentially …

RNA-dependent RNA polymerase as a target for COVID-19 drug discovery

W Zhu, CZ Chen, K Gorshkov, M Xu… - … the Science of Drug …, 2020 - journals.sagepub.com
COVID-19 respiratory disease caused by the severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2) has rapidly become a global health issue since it emerged in December …

[PDF][PDF] Elp1p, the yeast homolog of the FD disease syndrome protein, negatively regulates exocytosis independently of transcriptional elongation

PB Rahl, CZ Chen, RN Collins - Molecular cell, 2005 - cell.com
The activation of Rab GTPases is a critical focal point of membrane trafficking events in
eukaryotic cells; however, the cellular mechanisms that spatially and temporally regulate this …

Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS-S and MERS-S pseudotyped particles

CZ Chen, M Xu, M Pradhan, K Gorshkov… - ACS Pharmacology & …, 2020 - ACS Publications
While vaccine development will hopefully quell the global pandemic of COVID-19 caused
by SARS-CoV-2, small molecule drugs that can effectively control SARS-CoV-2 infection are …

Dual prenylation is required for Rab protein localization and function

M Calero, CZ Chen, W Zhu, N Winand… - Molecular biology of …, 2003 - Am Soc Cell Biol
The majority of Rab proteins are posttranslationally modified with two geranylgeranyl lipid
moieties that enable their stable association with membranes. In this study, we present …

[HTML][HTML] Drug repurposing screen for compounds inhibiting the cytopathic effect of SARS-CoV-2

CZ Chen, P Shinn, Z Itkin, RT Eastman… - Frontiers in …, 2021 - frontiersin.org
Drug repurposing is a rapid approach to identify therapeutics for the treatment of emerging
infectious diseases such as COVID-19. To address the urgent need for treatment options, we …

[HTML][HTML] Drug discovery strategies for SARS-CoV-2

ZA Shyr, K Gorshkov, CZ Chen, W Zheng - Journal of Pharmacology and …, 2020 - ASPET
Coronavirus disease 2019 (COVID-19) is a novel disease caused by the severe acute
respiratory syndrome coronavirus (SARS-CoV)-2 virus that was first detected in December of …

The SARS-CoV-2 cytopathic effect is blocked by lysosome alkalizing small molecules

K Gorshkov, CZ Chen, R Bostwick… - ACS infectious …, 2020 - ACS Publications
Understanding the SARS-CoV-2 virus’ pathways of infection, virus–host–protein interactions,
and mechanisms of virus-induced cytopathic effects will greatly aid in the discovery and …